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Abstract
Background: Marek's disease (MD) is a T-cell lymphoma of chickens caused by the Marek's
disease virus (MDV), an oncogenic avian herpesvirus. MD is a major cause of economic loss to the
poultry industry and the most serious and persistent infectious disease concern. A full-sib
intercross population, consisting of five independent families was generated by crossing and
repeated intercrossing of two partially inbred commercial White Leghorn layer lines known to
differ in genetic resistance to MD. At the F6 generation, a total of 1615 chicks were produced (98
to 248 per family) and phenotyped for MD resistance measured as survival time in days after
challenge with a very virulent plus (vv+) strain of MDV.
Results: QTL affecting MD resistance were identified by selective DNA pooling using a panel of
15 SNPs and 217 microsatellite markers. Since MHC blood type (BT) is known to affect MD
resistance, a total of 18 independent pool pairs were constructed according to family × BT
combination, with some combinations represented twice for technical reasons. Twenty-one QTL
regions (QTLR) affecting post-challenge survival time were identified, distributed among 11
chromosomes (GGA1, 2, 3, 4, 5, 8, 9, 15, 18, 26 and Z), with about two-thirds of the MD resistance
alleles derived from the more MD resistant parental line. Eight of the QTLR associated with MD
resistance, were previously identified in a backcross (BC) mapping study with the same parental
lines. Of these, 7 originated from the more resistant line, and one from the less resistant line.
Conclusion: There was considerable evidence suggesting that MD resistance alleles tend to be
recessive. The width of the QTLR for these QTL appeared to be reduced about two-fold in the F6
as compared to that found in the previous BC study. These results provide a firm basis for high-
resolution linkage disequilibrium mapping and positional cloning of the resistance genes.
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Background
Marek's disease (MD) is a highly contagious disease that
affects chickens worldwide and is caused by the Marek's
disease virus (MDV), an oncogenic avian herpesvirus.
MDV replicates in the lymphoid tissues [1] and is com-
monly manifested as an acute disease with lymphomas in
multiple visceral organs [2]. MD has a large impact on
production, making it the most costly viral disease in the
chicken industry [3]. It has also been proposed as a natu-
ral model for lymphomas that over-express Hodgkin's dis-
ease antigen (CD30) [4], and for understanding how
vaccines control lymphomas [5] and how pathogenic
viruses continue to evolve [6].
The current family selection methods used for improving
resistance are based on challenge exposure, and hence are
very expensive in terms of selection space, and the finan-
cial and ethical cost of routinely challenging large num-
bers of birds. It is anticipated that identification of QTL for
MD resistance will eventually allow marker-assisted selec-
tion on an individual bird level, without need for routine
challenge. This will greatly enhance the accuracy of selec-
tion, and reduce costs by orders of magnitude. QTL map-
ping, in conjunction with positional comparative cloning,
gene expression [7,8], and protein-protein interaction
studies [9,10] could also provide a platform for identifica-
tion of the genes underlying the QTL. The identification of
these genes will provide insight on disease pathways and
resistance mechanisms, leading to more effective vaccines
or other control strategies, and even more effective selec-
tion schemes based on gene-assisted selection [11].
Simulation and theoretical studies [12-14] show that large
scale BC or F2 experiments can locate QTL of moderate
allele substitution effect (0.2 or 0.3 standardized units)
only to within a confidence interval of 10 to 20 cM or
more. Consequently, Darvasi and Soller [15] proposed
the use of Advanced Intercross Lines (AIL) for fine map-
ping of QTL. An AIL is initiated by a cross between two
inbred lines, and continued by random intercrossing
through successive generations. Recombination events
between loci accumulate with the advance of the inter-
cross generations. The AIL approach has been applied suc-
cessfully in many mouse studies (e.g., [16]). A full-sib
intercross line (FSIL) [17] is a variant of the AIL that is
suitable for analysis of outcrossing populations. In a FSIL,
a single male and female from the same or different pop-
ulations, are crossed to produce a large full-sibship. The
full-sibs are mated at random, and the population contin-
ued by random intercrossing to advanced generations. To
a large extent, map expansion and QTL resolution in an
FSIL parallel that in an AIL.
Previous studies in commercial and non-commercial
White Leghorn populations have identified genes, QTL
and genomic regions associated with resistance to MD
(briefly summarized in [18]; see also [19]). Heifetz et al.
[18], using selective DNA pooling, identified 15 QTL
affecting MD resistance in a large reciprocal backcross
(BC) between two partially inbred commercial White Leg-
horn layer chicken lines that differed in resistance to MD.
Five of these QTL were previously reported by McElroy et
al. [20] in a smaller study of an independent hatch of one
of these BC populations, and four were previously
reported by Yonash et al. [21] in a study of an F2 popula-
tion generated by a cross between two inbred White Leg-
horn layer lines that differed markedly in resistance to
MD.
In the present study, a large F6 FSIL was generated as a
continuation of the same F1 population from which the
BC populations of McElroy et al. [20] and Heifetz et al.
[18] were derived. The objective of the study was to con-
firm previously mapped QTL, improve QTL map resolu-
tion, and uncover additional QTL segregating in this
population.
Results
Survival by family, B type and line
Table 1 shows characteristics of resistant and susceptible
pools according to family and MHC blood type (BT).
Table 1: Pool composition according to family (F) and MHC type 
(BT)
F BT Total No. Resistant Susceptible
No. Prop No. Mean Range
1 2/15 144 30 0.51 29 59.1 30–73
2/2 51 27 0.44 12 59.8 30–73
2/21 -- - 1 2 9 4 . 0 7 3 – 1 1 3
1 5 / 1 5 9 6 3 00 . 7 11 97 0 . 83 0 – 1 1 5
2 2/15 110 30 0.62 22 65.0 46–84
2/2 70 30 0.49 14 68.9 17–92
15/15 51 29 0.57 10 66.2 43–79
15/151 - - - 10 103.6 80–123
3 2/15 136 30 0.26 20 53.6 30–64
2/2 83 26 0.31 16 52.6 39–62
15/15 52 17 0.33 10 63.2 48–73
15/151 - - - 10 79.7 74–90
42 / 1 5 6 2 2 50 . 4 01 25 0 . 9 3 3 – 6 1
2/151 - - - 12 72.9 62–87
2/2 273 53 0.41 53 57.5 30–75
5 2/15 224 45 0.25 45 52.6 30–64
2/2 44 8 0.18 9 57.9 44–72
15/15 231 46 0.51 46 65.0 41–78
1 The number of individuals in the susceptible pools was low (10 to 12 
birds), hence an additional susceptible pool was created, which 
contained the next most susceptible 20% of birds.
Total No., total number of individuals in the F × BT combination; 
Resistant: number of individuals included in the resistant pool (No.), 
and proportion of individuals that survived to the end of test (Prop); 
Susceptible: number included in the susceptible pool (No.), with their 
mean and range of survival times in days.BMC Genomics 2009, 10:20 http://www.biomedcentral.com/1471-2164/10/20
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There was a clear effect of BT on resistance. The average
proportion of birds that survived the test for Families 1, 2,
3, 5 where all blood types were represented, was 0.36,
0.41 and 0.53 for blood types B2/B2, B2/B15 and B15/
B15, respectively. Similarly, the average survival time of
the birds in the susceptible pools for families where all
three blood types were represented was 56.8, 55.1 and
66.3 days for the B2/B2, B2/B15 and B15/B15 blood
types, respectively. Thus, blood type B15/B15 was clearly
more resistant, but the resistance appeared to be fully
recessive, as survival of the B2/B15 heterozygote was vir-
tually identical to that of the B2/B2 homozygote. Family
effects were also apparent, with Families 1 and 2 showing
higher proportions of survivors, and higher average sur-
vival times in the susceptible pools, as compared to the
other three families. In the ANOVA analysis, Family (p <
0.0001) and BT (p = 0.047) were both significant. The
results of the pure line chicks that were added to the exper-
iment as contemporary controls were 28.6% mortality for
Line 1 and 7.6% mortality for Line 2. This difference of
21.0% in favour of Line 2 was less than observed in previ-
ous trials, where the difference was 41.4% and 42.7% in
favour of Line 2 [18]. At 56.7%, the average mortality rate
was much higher in the F6 families than in the pure line
chicks but close to the target mortality for the challenge
test (50%).
Densitometric genotyping
All pools were densitometrically genotyped for microsat-
ellite or SNP markers as described in methods, and differ-
ences in allele frequency between resistant and susceptible
pools (D-values) were calculated. In order to validate the
markers that had high D-values, 35 microsatellite markers
were retested across the resistant and susceptible pools of
all family × BT combinations. The correlation between
first and second genotyping was calculated for each
marker separately across all pools. Except for one outlier
with a correlation of 0.52, the individual marker correla-
tions ranged from 0.70 to 1.0, with an average of 0.93.
Including the outlier, the overall correlation between the
two genotypings was 0.87. Since this correlation repre-
sents a double path (from first genotyping to actual pool
content, and from actual pool content to second genotyp-
ing), this observed correlation of 0.87 is equivalent to a
correlation of 0.93 between a single genotyping and
actual pool content. This high correlation confirms the
reliability and accuracy of the pool genotyping results as
representing the content of the pools. Nevertheless, since
both genotypings were done on the same pools, the high
correlation does not relate to the degree to which the con-
tent of the pools represents the genotypes of the individu-
als making up the pool.
Threshold PFP values for statistical significance
Table 2 shows the distribution of the comparison-wise
error rates (P-values) of all four statistical tests for marker-
QTL linkage: Z-test (Z), Chi-Square (CS), interval analysis
(IA), and ANOVA, into bins of width 0.10 units. On the
null hypothesis, the proportion of tests in each bin is
expected to be 0.10. For all tests except IA, there was an
excess of P-values in the lowest (0.00–0.10) bin, with the
proportion of P-values in this bin ranging from 0.16 for
ANOVA, to 0.25 for CS test. The estimated number of tests
representing linkage to a QTL (n1), was 63, 62, 510, and
38 for Z, CS, IA, and ANOVA. Taken as a fraction of all
tests (N), these comprised 22.9%, 22.5%, 4.0% and
13.8%, of all tests, respectively. Possible reasons for the
low proportion of tests representing linkage for the IA and
ANOVA tests are discussed in Methods.
Based on the distribution of marker P-values for the vari-
ous tests, P-values corresponding to the 0.20 PFP thresh-
old level were 0.026, 0.048 and 0.002 for Z, CS and IA,
respectively. For ANOVA, none of the marker tests reached
a 0.20 PFP threshold level. Nevertheless, in all cases, P-val-
ues for ANOVA tracked those for Z very closely. Thus, the
ANOVA provided strong support for the technical accu-
racy of the Z-tests, but did not provide information addi-
tional to that provided by the Z-tests. Hence, further
results for ANOVA are not presented or discussed.
The number of significant markers for each test, and the
statistical power of the test are also presented in Table 2.
Power was generally low, indicating that many additional
markers may have been in linkage to QTL but did not
Table 2: Distribution of P-values for ANOVA, Z-test, Chi-square 
(CS) and Interval analysis (IA)
Bin AN Z CS IA
0.0–0.1 0.16 0.20 0.25 0.08
0.1–0.2 0.15 0.13 0.13 0.09
0.2–0.3 0.07 0.11 0.09 0.12
0.3–0.4 0.09 0.09 0.06 0.09
0.4–0.5 0.11 0.08 0.07 0.14
0.5–0.6 0.09 0.06 0.07 0.09
0.6–0.7 0.08 0.08 0.10 0.07
0.7–0.8 0.08 0.07 0.06 0.06
0.8–0.9 0.08 0.09 0.08 0.10
0.9–1.0 0.08 0.08 0.09 0.16
N 275 275 275 12753
tN 237 212 213 12753
fN 38 63 62 510
PFP -- 0.026 0.048 0.002
oN 02 8 5 21 8 4
Power1 0.00 0.36 0.67 0.36
1 Power calculated as ON(0.80)/fN to account for 20% false positives 
included in ON.
N, the total number of tests; tN, the estimated number of tests 
representing true null hypotheses; fN the estimated number of tests 
representing falsified null hypotheses (i.e., true marker-QTL linkage); 
PFP, the 0.20 PFP CWER P-value thresholds; oN, the observed 
number of marker tests that passed the significance threshold; Power, 
the estimated power of the test; ND, not done.B
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Table 3: Markers significant for Z-test and/or Chi-square 
(CS): P-values for Z-test, CS and interval analysis (IA)
Marker Chromosome Pos Z CS IA Type
MCW0106 1 94 0.60 0.00 0.02 C
ADL1245 1 245 0.00 0.00§ 0.99 Z
ADL1248 1 248 -0.02 0.63 0.93
LEI0217 1 299 -0.03 0.00 0.14 ZC
HYL0238 2 45 -0.48 0.04 0.10 C
*ADL0270 2 46 -0.35 0.14 0.11
ADL0270r 2 46 -0.25 0.01 0.11 C
HYL0247 2 54 -0.98 0.01 0.11
MCW0063 2 119 0.01 0.67 0.62 Z
MCW0239 2 126 0.00 0.28 0.38 Z
ADL0157r 2 245 0.09 0.01 0.46 C
MCW0257 2 272 0.18 0.00 0.02 C
MCW0257r 2 272 0.15 0.00 0.02 C
*MCW0288 2 277 0.61 0.19 0.19
MCW0288r 2 277 0.40 0.01 0.19 C
MCW0051 2 358 0.02 0.03 0.02 ZC
MCW0051r 2 358 0.04 0.00 0.02 C
ADL2361 2 361 0.01 0.00 0.00 ZC
*MCW0245 2 364 0.11 0.10 0.03 C
MCW0245r 2 364 0.01 0.00 0.03 ZC
*ADL2374 2 374 0.04 0.82 0.61
MCW0282 2 378 0.01 0.29 0.17 Z
MCW0282r 2 378 0.00 0.09 0.17 Z
CPPP 3 292 0.00 0.05 0.22 ZC
MCW0005 4 75 0.26 0.01 0.30
*UMA4027 4 137 -0.12 0.26 0.18
UMA4027r 4 137 -0.07 0.03 0.18 C
*HYL0437 4 138 -0.14 0.09 0.17
HYL0449 4 144 -0.43 0.01 0.10 C
HYL0515 53 1 0 . 2 7 0 . 0 3 § 1.00
*ADL0292 5 83 -0.04 0.18 0.20
*ROS0052 5 90 -0.05 0.63 0.55
MCW0078 5 93 0.00 0.03 0.11 Z
*ADL0312 5 95 -0.06 0.52 0.39
ADL0023 5 96 -0.02 0.29 0.34 Z
MCW0081 5 152 -0.02 0.00 0.00 ZC
MCW0081r 5 152 -0.01 0.00 0.00 ZC
ADL0166 5 162 0.03 0.00 0.00 ZC
ADL0166r 5 162 0.02 0.00 0.00 ZCB
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ADL0298 5 198 0.02 0.00 0.11 ZC
ADL0298r 5 198 0.37 0.00 0.11 C
MCW0305 8 15 -0.70 0.00§ 0.97
HYL8003 8 40 0.00 0.00 0.47 ZC
HYL8033 8 59 -0.02 0.42 0.53 Z
ROS0307 89 6 0 . 4 2 0 . 0 0 § 0.99
LEI0028r1 95 1 0 . 5 0 0 . 0 3 § 0.65
LMU00061 9 51 -0.97 0.00§ 0.65
*HYL09281 9 55 -0.22 0.33 0.92
LEI01971 95 6 0 . 1 4 0 . 0 3 § 0.91
LEI0197r1 95 6 0 . 0 0 0 . 0 0 § 0.91 Z
ADL0259 9 122 -0.01 0.00 0.00 ZC
MCW0244 13 16 0.04 0.03 0.37 C
MCW00521 15 26 0.10 0.01§ 0.63
HYL1808 18 23 0.00 0.00 0.01 ZC
MCW0217 18 24 -0.07 0.03 0.01 C
MCW0217r 18 24 -0.06 0.02 0.01 C
*HYL1809 18 26 -0.04 0.07 0.03
HYL1816 18 32 -0.09 0.00 0.22 C
MCW0209 26 36 -0.15 0.03 0.28
*HYL2612 26 66 0.15 0.10 0.09
LEI0074 26 67 0.55 0.00 0.08 C
LEI0074r 26 67 0.26 0.04 0.08 C
ADL2668 26 68 0.64 0.00 0.01 C
*ADL2669 26 68 0.92 0.82 0.01
*ADL2669r 26 68 0.24 0.00 0.01 C
*ROS0309 Z 36 0.12 0.75 0.86
MCW0055 Z 37 0.00 0.01§ 0.63 Z
MCW0258 Z 42 0.02 0.24 0.81 Z
MCW0331 Z 43 0.02 0.11 0.86 Z
*ROS0301 Z 49 0.09 0.92 1.00
ADL0273 Z 52 0.33 0.01§ 0.53
MCW0241 Z 74 0.01 0.00§ 0.50 Z
MCW0227 Z 87 -0.23 0.03 0.24 C
LEI0121 Z 97 0.50 0.01 0.26 C
LPL Z 103 0.59 0.00 0.03 C
1These markers were significant for CS, but were not supported by IA. They are included in the list of QTLR, because they corresponded to QTLR previously mapped by [18].
PFP thresholds: Z, 0.028; CS, 0.048; *, Non-significant but part of a linked series of significant markers defining a QTLR; Italics, markers not included in final count of QTLR because significant only for a single test and marker; §, CS not 
supported by IA; Type, tests for which marker is significant; r at the end of a marker name represents a repeat test of the same marker; Spaces between rows delineate the individual QTLR.
Table 3: Markers significant for Z-test and/or Chi-square 
(CS): P-values for Z-test, CS and interval analysis (IA) (Continued)BMC Genomics 2009, 10:20 http://www.biomedcentral.com/1471-2164/10/20
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reach statistical significance. This is to be expected. As a
result of the map expansion in the F6, markers "move
away" from their QTL. Hence, the significance of the test
drops, reducing power, even though the marker is still in
linkage with the QTL. Power for CS was greater than for Z.
This is probably due to the fact that CS will often be sig-
nificant when Z is significant, and in addition, CS will also
be significant when interactions are important, while Z
will not be significant in these instances. Power for IA is
also presented, but does not carry much meaning, as the
proportion of tests estimated as representing linkage is
very low for this test.
QTLR
Table 3 shows P-values for Z, CS and IA for 60 markers for
which Z or CS, or both were significant at the PFP = 0.20
threshold. In addition, 14 markers are listed that were part
of a sequence of significant markers defining a QTLR,
although they did not reach significance for Z or CS. Of
the 60 markers with significant tests, 10 were not included
among the QTLR, because they were significant for a sin-
gle test only, or were not part of a sequence of two or more
markers each with at least one significant test. Of the
remaining 50 markers, 36 were significant for CS with
strong support from IA. Correspondence between CS and
IA is particularly striking in the instances where both dif-
fered widely from Z. Eight markers were significant for CS,
but were not supported by IA, and hence were initially not
considered as significant for purposes of QTLR definition.
However five markers (on chromosomes 9 and 15) that
were excluded initially as not meeting criteria, were
included among the final list QTLR, because they corre-
sponded to QTLR previously mapped by [18]. This
returned four markers that were significant for CS, but not
supported by IA. In all, 52 markers were considered as
defining QTLR. Of these, 27 were significant for CS only,
while 25 were significant for Z, of which 11 were signifi-
cant for Z only and 14 were significant for Z and CS. Joint
significance of Z and CS basically means that CS is sup-
porting Z, since large uni-directional D values will gener-
ate significance for both tests. Since power for CS is less
than for Z, it is expected that some markers will be signif-
icant for Z but not for CS. Thus, about half of the signifi-
cant markers represented significant main effects, while
the other half represented significant interaction effects
without significant main effects.
Based on Table 3, QTLR and non-Q regions, as defined in
Methods, are listed in Table 4, which shows the total
number of markers in each region (counting also non-sig-
nificant markers incorporated within a QTLR) and the
location of the markers defining the start and end points
of each region. For QTLR, the statistical tests for which the
region is significant, the estimated allele substitution
effect on survival time, and overlap with regions of signif-
icance in Heifetz et al. [18] and Yonash et al. [21] are also
shown. A total of 21 QTLR were identified. Of these, 8
were significant for CS only, while 13 were significant for
Z either alone (6) or for Z as well as CS (7). For six of the
regions, QTL location and confidence interval, as deter-
mined by IA, are also shown in the table.
Eight of the QTLR corresponded to QTLR that were previ-
ously identified by Heifetz et al. [18] in the reciprocal BC
populations generated from these lines. As noted above,
however, two of these (QTLR 9-II and 15-II) were of bor-
derline significance in the F6 and were included among
the F6 QTLR because of support from the Heifetz et al.
[18] study. In addition, three of the QTLR corresponded
to significant QTL reported by Yonash et al. [21], of which
one was also reported in the Heifetz et al. [18] study. Thus
11 out of 22 QTLR identified in the F6 were supported by
other studies of these lines or of other Leghorn layer lines.
The total absolute allele substitution effect summed
across all 21 QTLR was 95.84 days, with a mean absolute
allele substitution effect of 4.56 days. This compares well
with the mean absolute allele substitution effect of 5.53
days for the QTLR identified in the Heifetz et al [18] study
when based on combined data of the two BCs. Of the 21
QTLR, 14 presented positive effects, indicating that the
resistant allele originated from Line 2 (the more resistant
line), and 7 presented negative effects, indicating that the
resistant allele originated from Line 1 (the less resistant
line). This corresponds to the results of the BC analysis
[18], in which case also resistance alleles originating from
Line 1 were uncovered. The total summed effect for sur-
vival time, across all 21 loci including algebraic sign, was
27.20 days in favor of Line 2. Although not directly com-
parable, this is in accord with the observed difference of
21.0% in proportion of survivors in favor of Line 2, found
in the present study.
When some of the same QTL are uncovered in independ-
ent genome scans, this supports the validity of these QTL.
However, since independent scans will have some QTL in
common and some that differ, it is always possible that at
least some of the shared QTL represent chance Type I
errors that happened to occur in the same chromosomal
region. The likelihood of this decreases when the com-
mon QTL share specific qualities, other than their quanti-
tative effect. For example, in a previous study of QTL
affecting milk yield and protein percent in Brown Swiss
dairy cattle [22], it was found that QTL identified in the
Brown Swiss breed shared specificity (for milk yield or for
protein percent, or both) with those identified in the Hol-
stein breed. This was taken as strong support for the reality
of these QTL. Similarly, in the present study, the identified
QTL have specificity in terms of direction of effect
(whether the allele derived from the more resistant line
had a positive of negative effect on resistance) and magni-
tude of effect. It is striking, therefore, that of the 8 QTLRB
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Table 4: Chromosomal regions that contain QTL (QTLR) and that do not contain QTL (non-Q)
Chr Reg. Type M Test Location (cM) Effect (days) BC/Yonash
1 I Non-Q 2 33–79
II QTLR 1 ZC 94; 95 (85–101) 1.62
III Non-Q 10 122–243
IV QTLR 2 Z 245–248 0.39
V Non-Q 15 259–523
2 I Non-Q 1 44
II QTLR 3 C 45–46; 45 -2.49 Y (34–60)
III Non-Q 13 47–113
IV QTLR 2 Z 119–126 7.81 BC 5.741 (82–112)
V Non-Q 17 155–261
VI QTLR 4 C 272–277: 273 (269–275) 2.88
VII Non-Q 5 278–326
VIII QTLR 5 ZC 358–364; 361 (343–368) 6.53
IX QTLR 3 Z 374–378 7.18
X Non-Q 4 389–400
3 I Non-Q 16 9–291
II QTLR 1 ZC 292 -8.00
III Non-Q 1 295
4 I Non-Q 11 50–125
II QTLR 4 C 137–144 -4.69 Y (106–124)
III Non-Q 8 148–188
5 I Non-Q 9 8–34
II QTLR 5 Z 83–96 -5.46
III Non-Q 2 106–122
IV QTLR 4 Z 152–162: 162 (160–165) -1.15 BC -3.561(140–153)
V Non-Q 2 168–198
VI QTLR 2 C 198 4.74
6 I Non-Q 4 41–141
7 I Non-Q 5 0–135
8 I Non-Q 8 8–39
II QTLR 1 ZC 40 11.25 BC 9.78 (43–56)
Y (30–38)
III Non-Q 9 41–109B
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9 I Non-Q 9 43–50
II QTLR 5 C 51–56 2.07 BC 4.52 (48–56)
III Non-Q 2 57–71
IV QTLR 1 ZC 122: 124 (101–134) -7.00
11 I Non-Q 2 0–68
13 I Non-Q 7 16–44
15 I Non-Q 11 1–26
II QTLR 1 ZC 26 4.69 BC 6.40 (3–39)
III Non-Q 1 39
18 I Non-Q 2 7–20
II QTLR 5 ZC 23–32: 23 (22–28) -5.53
26 I Non-Q 3 33–38
II QTLR 6 C 66–68: 64 2.15
Z I QTLR 6 Z 36–52 5.87 BC 9.131(0–49)
II QTLR 1 C 74 4.04 BC 5.951(52–74)
III QTLR 3 C 87–103 0.30 BC 7.771 (103–115)
IV Non-Q 1 115
1 Also supported by McElroy et al., (2006)
Chr., chromosome; Reg., region; M, number of markers in the region; Test, Z, significant by Z-test; C, significant by Chi-square and supported by IA; Location, cM of the 
markers flanking the region, in italics following semi-colon location and (confidence interval) by IA; Effect, allele substitution effect of the region; BC, allele substitution effect 
and location in Heifetz et al. (2007); Y, region of significance in Yonash et al. (1999).
Table 4: Chromosomal regions that contain QTL (QTLR) and that do not contain QTL (non-Q) (Continued)BMC Genomics 2009, 10:20 http://www.biomedcentral.com/1471-2164/10/20
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that were found in the present study and also in the
Heifetz et al. [18] study, the same 7 had positive effects in
both studies, and the same one had a negative effect in
both studies. The likelihood of either of these events is
low, although within the realm of chance. Furthermore,
the correlation between estimated signed allele effects of
the common QTLR in the F6 and BC was 0.67 (P < 0.03);
the correlation increased to 0.84 (P < 0.001) if an excep-
tional value (for QTLR Z-III) is excluded. Thus, the nearly
significant correspondence of algebraic sign for the com-
mon QTLR of the two studies, and the significant correla-
tion of their estimated effects strongly supports their
underlying reality. The preponderance of positive effects
among the QTLR that were common to the two studies,
suggest that these are The QTLR that contributed to the
superior resistance of Line 2.
The mean minimum and maximum width of the QTLR
identified in this study was 4.73 and 14.93 cM respec-
tively; if QTLR defined by a single marker are excluded,
the minimum extent becomes 7.42 cM. The mean extent
of a QTLR, as defined by IA was 17.0 cM. Comparable val-
ues calculated for the QTLR defined in the Heifetz et al.
[18] BC study (calculated from Table 3 of [18]) were a
minimum extent of 13.4 cM (20.3 cM when excluding
QTLR defined by a single marker); a maximum extent of
34.1 cM, and a mean extent from IA of 24.6 cM. The mean
extent for the F6 QTLR, defined by all four measures, was
11.02 cM; the corresponding value for the BC QTLR was
23.00. Thus, QTL map resolution appears to have been
reduced by half in the F6 as compared to the BC popula-
tions. This corresponds almost exactly to the calculated
degree of map expansion in this population based on
unpublished data (J.E. Fulton and E. Lipkin pers. comm.).
Discussion
MHC type B15/B15 was clearly more resistant than B2/B2
and B2/B15, but the resistance appeared to be fully reces-
sive, as the heterozygote was virtually identical to the B2/
B2 homozygote. Similar results were obtained in the
reciprocal backcross study of these founder lines [18]. This
was somewhat unexpected, as a number of studies com-
paring the influence of various MHC haplotypes on MD
in different strains of chickens found that the B2 haplo-
type is frequently associated with greater resistance
[23,24]. These data are, however consistent with others
that suggest that some genes may interact to complement
the MHC haplotype influence [25].
The QTL results of this study accord well with those of the
previous reciprocal backcross study of these lines [18]. In
the BC case, a total of 15 QTLR were identified. Of these,
3 QTLR were significant for CS only, 12 were significant
for ANOVA or Z, of which 8 were also significant for CS.
Three-fifths of the QTLR identified in the previous study
were also identified in the present study, and the effects of
the common QTLR were identical in sign, and highly cor-
related in magnitude.
Considering the three main MD resistance QTL-mapping
studies, the present F6 and the BC [18] experiments
between them identified all four of the significant Yonash
et al. [21] QTL; 8 QTL were common to the F6 and BC [18]
experiments; while 13 and 7 were uniquely identified by
the F6 and BC [18] experiments, respectively. Thus,
among them these experiments uncovered a total of 28
QTL affecting MD resistance. Lack of full correspondence
between the present F6 and previous BC [18] experiments,
which were carried out in populations derived from the
same founder lines, can be attributed to the partial power
of the experiments. Assuming a total of 28 QTL, power of
the F6 experiment would be 0.77 (21 out of 28) and that
of the BC experiments would be 0.54 (15 out of 28).
These power estimates seem reasonable considering the
size and design of the experiments and magnitude of the
QTL effects uncovered, and the difference between the
power estimates for the F6 and BC experiments is far from
statistical significance. For experiments of comparable
size and QTL of comparable effects, F2 and reciprocal
backcross designs should provide equivalent statistical
power [26]. Thus the observed difference in power of the
two experiments is best attributed to sampling variation.
Overall, Line 2 contributed about twice as many resistance
alleles as Line 1, as would be expected from the relative
resistance of the two lines. Curiously, in the present study,
the pure line controls of Line 1 and Line 2 displayed much
higher resistance (28.6 and 7.6% mortality to end of test,
respectively), compared to the F6 (52.7% mortality to end
of test). Thus, interactions of the background genome
appear to have major effects on the expression of resist-
ance [27]. The fact that the cross of the two lines was more
susceptible than each of the individual lines is consistent
with other indications that the QTL alleles that confer
resistance in these lines are recessive, so that the cross
shows negative heterosis for resistance. This stands in
some contrast to the results of Stone [28], who conducted
a number of crosses between ADOL resistant and suscep-
tible lines and concluded that MD resistance was domi-
nant, and of Yonash et al. [21], who found that at a
majority of their identified QTL, the resistant alleles were
dominant. The results are, however, consistent with the
Heifetz et al. [18] study, in that QTL mapping in the recip-
rocal backcross populations developed from these
founder lines identified different QTL, as would be
expected if QTL for resistance are recessive. The hypothesis
that resistance alleles are recessive also predicts that the F6
should identify QTL that came to expression in both of
the reciprocal BC populations. In this regard, eight of the
QTL identified in the BC populations corresponded toBMC Genomics 2009, 10:20 http://www.biomedcentral.com/1471-2164/10/20
Page 10 of 17
(page number not for citation purposes)
QTL identified in the F6. Of these, one was specific to
BC1, three were specific to BC2, and four were found in
both BC's. Seven of the QTL mapped in the BC, however,
did not have corresponding QTLR in the F6. The simplest
explanation for these negative results may be the incom-
plete power of the two experiments, which appreciably
reduces the likelihood that the same QTL will be found in
the two experiments.
Three of the QTLR identified in the F6 were also identified
in the Yonash et al., [21] study. This is particularly note-
worthy, since the challenge strain in the Yonash et al. [21]
study was JM/102W, which is a virulent (v) MDV strain,
but less pathogenic than the vv+ MDV strain 648A used in
the present study. Thus, this lends some support to the
widely held assumption that QTL conferring resistance to
one MDV strain will confer resistance to another as well,
at least in White Leghorns where genetic diversity is lim-
ited.
Considering QTL map locations in the BC as compared to
the F6, there is a clear tendency for distinctly narrower
QTLR in the F6 than in the BC; average QTLR extent in the
F6 was just about half that in the BC, as anticipated from
the observed map expansion in the F6. Additional geno-
typing at higher marker density across the QTLR is clearly
warranted to obtain full benefit of the F6 map expansion.
Counting all resistance QTL uncovered in the two BC pop-
ulations by Heifetz et al. [18] and in the F6 in the present
study, gives a total of 28 QTL; eight common to both
series of crosses, 13 uncovered only in the F6, and 7
uncovered only in the BC populations. Of the 8 common
QTLR, 5 were significant by Z or by Z and CS, indicating
important main effects. These results should provide a
strong platform for comparative positional cloning, after
confirmation of the associations by individual genotyping
of the pools. Comparative functional genomics based on
the complete chicken genome sequence could be used to
identify candidate genes in the identified chromosomal
regions. As a preliminary exercise, we have searched Build
2 of the chicken genome across 5 cM centered at each of
three regions which had narrow widths in the present
study, and corresponded to regions of significance in [18]
or [21], namely: QTLR 2-II (supported by [21]), centered
at ADL0270 at about 9.7 Mb; QTLR 8-II (supported by
[18] and [21]), centered at HYL08003 at about 18.5 Mb;
and QTLR 9-II (supported by [18]), centered at LEI0197 at
about 13.0 Mb. The most likely candidate gene in QTLR 2-
II is PTPRN2 (protein tyrosine phosphatase, receptor type,
N polypeptide 2) at 8.7 Mb (1 Mb downstream of
ADL0270). PTP family members are signalling molecules
that regulate many cellular processes, including cell
growth, and have been implicated in oncogenic transfor-
mation. QTLR 8-II contains two interesting candidate
genes: CD97 antigen, at 19.2 Mb (~0.7 Mb downstream of
HYL08003) and PIGK (phosphatidylinositol glycan, class
K), at 19.9 Mb (~1.4 Mb upstream of HYL08003). CD97
antigen is a receptor involved in cell adhesion and signal-
ling, that is present on the surface of most activated leuko-
cytes. MDV is thought to infect and transform only
activated CD4+ T cells. Consequently, cell adhesion might
assist the virus transmission from one infected cell to
another, as MDV is highly cell associated. PIGK is a subu-
nit of the GPI transamidase complex that catalyzes the
attachment of GPI (glycosylphosphatidulinositol) to pro-
teins. GPI is a membrane anchor for cell surface proteins.
As such it provides for rapid protein release in response to
a stimulus, since the protein bound by the GPI anchor can
be immediately released without a requirement for RNA
or protein synthesis. In this context it is relevant that SCA2
(stem cell antigen 2) has a GPI anchor, and is one of the
most strongly documented MD resistance genes [9]. For
QTLR 9-II, using LEI0197 (at 13.0 Mb) as the reference
point, we were unable to find any attractive candidate
genes. This may in part be because the biology of MD
resistance is not well defined. A further contributing factor
is the fact that much of the chicken gene annotation is
inferred by electronic annotation and not by experimental
evidence. Consequently, one can speculate about almost
any gene being involved in viral replication and spread, or
cellular transformation, especially as the biomedical liter-
ature is slanted heavily towards cancer.
These and other candidate genes can be screened further
by examining their mRNA expression pattern under MDV
challenge, using existing data banks. However, they could
also readily be examined for linkage disequilibrium with
MD resistance by constructing appropriate resource popu-
lations using the existing data and sample banks accumu-
lated at Hy-Line through the routine MD challenge and
testing component of their regular commercial breeding
program. Such association tests could also be imple-
mented by selective DNA pooling, perhaps using the new
fractioned pool designs [29] to increase power and accu-
racy.
Conclusion
If the resistance alleles are recessive and at low to moder-
ate allele frequencies, this would explain the slow
response to selection for increased resistance, and
enhances the need for mapping in order to increase the
effectiveness of selection on these QTL within the pure
lines. Because most chickens used for commercial egg or
meat production are crosses between 2 to 4 lines, it will be
important that the recessive resistance alleles are present
in all pure lines, such that the cross will be homozygous
for the resistance QTL. For lines that lack the resistance
alleles, which would need to be determined as a first step,
it might be most effective to introgress resistance alleles
from one line to another. Achieving this, without losing
the heterosis for production traits that characterizes theBMC Genomics 2009, 10:20 http://www.biomedcentral.com/1471-2164/10/20
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cross of these commercial lines, could only be achieved
through marker or preferably gene assisted introgression
focused on the limited genome regions carrying the resist-
ance alleles.
Methods
Resource population
Stocks
The experiment was carried out using facilities and two
commercial White Leghorn lines (henceforth, Line 1 and
Line 2) of Hy-Line International (henceforth, Hy-Line).
Both lines were partially inbred and had been subjected to
selection for resistance to MD, and both were relatively
resistant when compared to field strains of poultry. How-
ever, under the same challenge protocol as the present
study, Line 2 was distinctly more resistant than Line 1.
Further details of these lines are in Heifetz et al. [18].
Experimental populations
In order to provide replication and some indication of
QTL segregation within the two lines, the F6 FSIL was pro-
duced in five independent replicates, termed "FSIL-fami-
lies", as follows (Figure 1): Five Line 1 males were each
pair-mated with a single Line 2 female, to produce an F1
generation consisting of five large and independent full-
sib F1 families. Each of these F1 families served as the
founder of one of the replicate FSIL-families. Within each
of these five F1 founder families, 7–10 males were ran-
domly mated to two females each, to produce seven F2
subfamilies within each of the five FSIL-families. Each of
the F2 subfamilies within each of the five FSIL-families
was then continued by crossing full-brother and sister
within the subfamily for another two consecutive genera-
tions, creating at the F4 generation five replicate FSIL-fam-
ilies, each consisting of 7 partially inbred subfamilies.
This was done to maintain genetic diversity within each
family, while still accumulating recombination events. At
the F4 generation, males from each of the seven sub-
families within each FSIL-family were crossed to females
of other subfamilies within their own FSIL-family (but not
with their own full-sisters, or with females of the other
FSIL-families). In this way, the five separate F5 FSIL-fami-
lies were reconstituted. In the F5 generation, a total of
about 30 males and 120 females per FSIL-family were cho-
sen and mated at random to produce the five independent
F6 replicate FSIL-families, which constituted the mapping
population. The F6 birds were produced in two hatches,
with a total of 862 and 753 female chicks for Hatches 1
and 2, respectively. The total number of female F6 birds
within each of the five FSIL-families with full data (sur-
vival time, MD diagnosis) ranged from 98 to 248.
MD challenge test
Day-old female F6 chicks from the two hatches were vac-
cinated with 500 plaque forming units (pfu) of bivalent
HVT/SB-1 vaccine (Merial Select, Gainesville, GA, 30503)
and then housed in cages. A total of 200 pure line chicks
from each of the two parental lines were included as con-
trols for each hatch of the F6 (800 chicks total). At 7 days
of age, the chicks were inoculated subcutaneously with
500 pfu of the very virulent plus (vv+) strain (648A) of
MDV [30]. Age at mortality was recorded on all chicks, as
an indicator of MD resistance, until 116 and 123 days of
age for Hatches 1 and 2 respectively, at which time
remaining birds were terminated. Under normal circum-
stances, mortality in these lines is virtually zero (0.5%)
from 2 to 18 weeks of age. Under challenge, MD mortality
does not begin until four weeks of age at the earliest. After
this age, however, virtually all mortality in the challenged
birds is due to MD. Therefore, any chick that died after 21
days was considered to have died from MD, without pos-
itive diagnosis by necroscopy. At the end of the experi-
ment at 18 weeks (126 days, just prior to entry into lay),
the birds were visually examined and any birds that were
blind, lame or completely paralyzed were identified as
having MD. However, birds with mild symptoms or birds
that had recovered, were not recognized as such, and
hence were classed as survivors. Thus, the resistant pools,
which were made up of survivors, may also have included
some proportion of susceptible birds with MD tumours.
Target mortality for the challenge test averages about 50%,
but in any particular hatch this varies considerably, from
30 to 70%. The challenge test and diagnosis procedure has
been shown to be repeatable and to result in data with
substantial heritability for sire progeny averages based on
30 daughters (pers. comm., Neil O'Sullivan, Hy-Line Int.).
DNA extraction and pool construction
In order to reduce the number of genotypings while limit-
ing loss of power, the selective DNA pooling method
[31,32] was used. This method has proven very accurate in
our laboratory [33]. Ten and six days post infection for
Hatches 1 and 2, respectively, blood was collected from
the jugular vein in syringes containing EDTA with 22
gauge needles. DNA was prepared using salt and ethanol
precipitation. The OD 260/280 ratios were determined
and each sample was diluted to approximately 50 ng/μl
DNA concentration. DNA content was retested and fur-
ther diluted to 25 ng/μl. Pools of DNA were made by com-
bining equal volumes of the 25 ng/μl samples from each
bird in the pool.
Mortality rate was very similar for the two hatches (56.2
and 57.2%, respectively) and was also consistent across
hatches for the five families considered separately (data
not shown). For each F6 family, therefore, chicks from the
two hatches were combined when forming pools. There
were three blood type (BT) groups in each F6 family: B2/
B2, B2/B15, and B15/B15. To account for the well known
effects of MHC blood type on resistance to MD [34-36],
birds were pooled within B blood groups. For selective
DNA pooling, progeny within each family × BT combina-BMC Genomics 2009, 10:20 http://www.biomedcentral.com/1471-2164/10/20
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tion were ranked by age at mortality and the top and bot-
tom 20% from each combination were chosen for the
pools (Table 1). This gave 30 pools in total (5 families × 3
BT × 2 tails (high and low)). However, the Family 4 × B15/
B15 combination had only 5 birds in total, which reduced
the total number of pools to 28. The remaining pools
ranged in size from 9 to 53 individuals. For most of the
susceptible pools, the cut off survival age to be included in
the pool varied from 62 to 79 days. However, two pools
(Family 1 × B15/B15, and Family 2 × B2/B2) included
birds surviving up to 115 and 92 days, respectively. In
family × BT combinations with small numbers, the
number of individuals in the susceptible pools was low
(10 to 12 birds), hence an additional susceptible pool
(Type II pool) was created, which contained the next most
susceptible 20% of birds (cut off points demarcating the
two pools can readily be inferred from the range column
of Table 1). There were four susceptible pools of this type.
With respect to the resistant pools, in most family × BT
combinations the proportion of surviving (i.e., resistant)
birds exceeded 20%, since overall survival to end of test
was 56%. In this case, birds for the resistant pools were
chosen so as to ensure that each hatch was equally repre-
sented. In all, then, there were a total of 32 pools: 14
resistant pools and 18 susceptible pools (14 type I and 4
type II).
Genotypic information
Markers
Microsatellite markers were chosen that had alleles differ-
entiating the two lines. Genotyping of pools was per-
formed in two rounds. The first round included 182
markers, chosen to provide representative genome cover-
age. Based on the first round of genotyping, 35 markers
that gave a suggestive result were genotyped again on the
same pools. These results were treated in the final analysis
as though they were new markers at the same location. In
addition, in 10 regions that showed results of special
interest in the first round, 50 new markers were added,
among them 35 microsatellites and 15 SNPs. Thus, in
total the pools were genotyped for 232 markers: 15 SNPs
and 217 microsatellites. However, since 35 markers were
genotyped twice, and the replicates were treated as new
markers, all told there were 267 single-marker statistical
tests. The chromosomal regions spanned by the geno-
typed markers summed to a total of 2477 cM. Adding 10
cM upstream and downstream of the most distal and
proximal markers for each of the 15 scanned chromo-
somes would add another 300 cM, giving a total of about
2800 cM, or about 70% of the chicken genome. The aver-
age distance between markers on the same chromosome
was ~17 cM, with a maximum interval of 107 cM on chro-
mosomes 3.
Marker position
The interval analysis method used for QTL mapping
requires recombination rates between markers. To obtain
these rates, markers were positioned on a linkage map
based on the consensus 2000 map [37]. When there was a
discrepancy between the consensus map and the pub-
lished Build 1 genome sequence [38], the order of the
markers was taken according to the sequence and markers
were positioned as described in Heifetz et al. [18].
Genetic distances between markers in cM, as given in the
public marker maps, are based on data obtained in F2 or
BC populations, and hence represent effects of a single
round of recombination. For AIL, infinitesimal map dis-
tances expand according to the expression dt = 1/2 td,
where dt is map distance in the F(t) generation, and d is
the map distance in the F2 generation [15]. According to
this expression, for an F6 population, the overall expan-
sion factor is three-fold. For interval analysis, map dis-
tances calculated in this manner were transformed to
recombination rate (r) values using the Haldane map
function. The three-fold map expansion applies to AIL
with random mating. Here, the lines were propagated by
brother-sister matings to generate the F3 and F4 genera-
tions, which created some level of inbreeding and may
have reduced the actual expansion of the map. Indeed,
studies under way indicate that the realized expansion
was two-, rather than three-fold. Therefore, the interval
analysis was done using marker maps calculated with an
expansion factor of 2, 3 and 4 to check the sensitivity of
the results to this parameter.
The experiment design Figure 1
The experiment design.
Male line Female line
Family 1 Family 2 Family 3 Family 4 Family 5
sf31
sf35 sf36 sf37
sf34 sf33 sf32 7 Sub-
families
7 Sub-
families
7 Sub-
families
7 Sub-
families
7 Sub-
families
7 Sub-
families
7 Sub-
families
7 Sub-
families
7 Sub-
families
7 Sub-
families
7 Sub-
families
7 Sub-
families
7 Sub-
families
7 Sub-
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Family 1 Family 2 Family 3 Family 4 Family 5
Family 1 Family 2 Family 3 Family 4 Family 5
F0
F2
F3
F4
F5
F6
F1
Within-family across sub-family, matings      
Within-family across sub-family, matings     
Single pair matings to produce full-sib families
Single pair matings within families to produce subfamilies (sf)
Full sib matings
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Genotyping methods
Genotyping for the B group was done by standard serotyp-
ing using B2 and B15 specific reagents. For the microsatel-
lite markers, allele frequency differences between high
and low pools were estimated as described by Heifetz et
al. [18]. For eight of the SNP markers, relative allele fre-
quencies were determined by pyrosequencing. In brief,
mini-sequencing primers were designed by the Pyrose-
quencing Assay Design Software (version 1.0) (Biotage,
Uppsala, Sweden). The forward, biotinylated reverse, and
sequencing primers were synthesized by Operon (Hunts-
ville, AL). Fragments were amplified in a total volume of
40 μl by PCR as described by Liu and Cheng [39]. The
biotin-ssDNA was isolated by binding PCR amplicons to
streptavidin sepharose (Amersham Biosciences, Uppsala,
Sweden) followed by denaturation with 0.2 M NaOH. The
mini-sequencing primer was annealed to the ssDNA, and
the sequencing reactions were initiated using a nucleotide
dispensation order based on the sequence. The PSQ96MA
analysis program (Biotage, Uppsala, Sweden) calculated a
percentage for each base at the SNP using the surrounding
peaks as reference values. Controls included absence of
template and known homozygous and heterozygous indi-
viduals. Using the same procedures but calling genotypes
instead of allele frequencies, the remaining seven SNP
markers were genotyped individually on all individuals
that constituted the pools. For these markers the fre-
quency in each pool was the actual frequency of the alleles
in the pool and was treated in the analyses as a pool fre-
quency estimate.
Statistical methods
Frequency estimates and D-values
Following Lipkin et al. [32], the frequencies of alleles at
each microsatellite marker estimated from pools were cor-
rected for differential amplification and for the shadow
bands that are inherent to microsatellite markers. The
basic datum that was used to identify markers that are
associated with QTL for MD was the difference (Dijk) in
allele frequency of the ith marker between the resistant and
susceptible pools of the jth BT × kth family combination:
Dijk = dFijk1 - dFijk2, where dFijk1 and dFijk2 are the densito-
metric estimates of the frequency of the marker allele
derived from Line 2 in the resistant and susceptible pools,
respectively.
A total of 18 Dijk were calculated for each marker. These
included 14 Dijk based on the resistant pools and the Type
I susceptible pools; and an additional four Dijk based on
the four Type II susceptible pools and their corresponding
resistant pools (which are the same as for the correspond-
ing Type I pools). Although the four Type II Dijk are not
independent of their corresponding Type I values (since
they are from the same test population and were con-
trasted to the same resistant pool), they were considered
as being independent in the analyses which follow.
The Dijk were evaluated for significance using a variety of
statistical tests that were calculated across all 18 blood
type × family (BFjk) combinations within each marker,
namely: Z-test, Chi-square (CS), interval analysis (IA),
ANOVA, and nonparametric Sign Test. The Z, CS and Sign
tests were carried out using Excel; ANOVA was imple-
mented using the Fit Model in JMP 5.1.2 Statistical pack-
age (1989–2004 SAS Inst. Inc.); IA was implemented by
EH using programs provided by JW. Further detailed
expressions and descriptions of the various tests are given
in Heifetz et al., [18] and will not be repeated here. Each
of these tests explored a somewhat different aspect of the
data. In particular, the Z-test evaluates the main effect of a
marker allele on Dijk across all BT × family (BF) combina-
tions. Thus, the Z-test is sensitive to main effects and pro-
vides an estimate of the direction of the effect of specific
alleles, but is insensitive to marker-BT-family interaction
effects. The Chi-square test analyzes Dijk within each BF
combination, allowing for different directions of effects
and is, therefore, less sensitive to main effects than the Z-
test but more sensitive to interaction effects. The Z- and
Chi-square tests are both based on analysis of single mark-
ers. To take into account the additional information
present in adjacent markers, Dijk for all markers on a chro-
mosome were analyzed jointly using a likelihood-based
interval mapping (IA) method [40], as implemented by
Heifetz et al. [18] for a backcross but with additional
adjustments for autosomal and Z chromosomes in an F6
population. By analyzing each BF combination as a sepa-
rate family, the IA shares with Chi-square its sensitivity to
interaction effects but is also less powerful than the Z-test
to detect main effects. These three tests are based on the
Dijk divided by their standard errors (SE). Two additional
tests: a three-way ANOVA (marker × blood type × family)
and a nonparametric sign test were also used. These,
although based on the same Dijk, each use a different basis
to test significance, in this way providing an additional
control to the statistical calculations. Both ANOVA and
the Sign Test share with the Z-test its sensitivity to main
effects and insensitivity to interaction effects. The Sign
Test was used primarily as a check on the Z-test and
ANOVA, and proved effective in indicating technical
errors in the analysis, but will not be presented or dis-
cussed in detail. Mean Square error in the ANOVA was
estimated from the pooled interaction effects, rather than
from replicated markers. Hence, considering that signifi-
cant interaction effects were present in this population,
the MS error term would have been subject to upward
bias, which increases P-values for this test, decreasing
power relative to the Z-test.
Accounting for multiple tests
To take into account the multiple test situation while
retaining power, a 20% "proportion of false positive
(PFP)" threshold was used to determine the critical com-
parisonwise error rate (CWER) or P-value for declaringBMC Genomics 2009, 10:20 http://www.biomedcentral.com/1471-2164/10/20
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marker-QTL linkage [41], where PFP for the ith test is cal-
culated as:
PFPi = (PitN)/Ri
Pi is the P-value of the ith test, when the N tests are ranked
by their P-values from lowest to highest,
Ri is the rank number of the ith test, and
tN is the number of tests for which the null hypothesis is
true.
Estimation of tN was by the Nettleton et al. [42] algorithm
for ANOVA, Z and CS (see also [18]).
Given an estimate of tN, the number of tests representing
falsified null hypotheses, fN (i.e., tests representing true
marker-QTL linkage), can then be estimated as fN = N - tN,
and effective power, as oN/fN where oN is the number of
tests that are significant according to the designated signif-
icance level.
For the IA test, the simplified algorithm of [43] was used
to estimate tN, which works well when tN is almost equal
to N. The PFP calculation was done using all IA tests that
were conducted on a chromosome at 1 cM intervals on the
expanded map, as in the range of CWER values > 0.001
there was a fairly smooth and monotonic relationship
between rank number and PFP (see also figure 2 of [44]).
On this basis, PFP calculation was done using all IA tests
that were conducted on a chromosome at 1 cM intervals
on the expanded map.
Effect of added markers and map expansion on PFP 
threshold levels
As noted above, genotyping was performed in two
rounds. Markers used in the first round were chosen to
provide good genome coverage, but without relation to
previously identified genes or QTLR affecting MD resist-
ance. However, the 85 markers used in the second round
were specifically targeted to "suggestive" regions uncov-
ered in the first round. These were either repeat genotyp-
ings of the suggestive markers themselves (35 markers) or
additional markers targeted to the suggestive regions (50
markers). Thus, the actual proportion of positives can be
expected to be greater among the second round markers
than among the first round markers. Combining the two
sets of markers in a single PFP analysis, as was done in the
present study, will increase the actual proportion of posi-
tives among all markers and, hence, can be expected to
render the PFP thresholds somewhat less stringent relative
to those appropriate to the first set of markers, but more
stringent relative to those appropriate to the second set of
markers. This consideration will be more important for
the single marker tests (ANOVA, Z, CS) than for IA, since
IA deals with chromosomal regions and the number of
markers in a significant region is not material.
With respect to the effect of map expansion on PFP thresh-
olds, for Z, ANOVA, and CS the effect of map expansion
should be to increase average distance between markers
and QTL, and hence increase P-values for all markers
except those that are very close to the QTL. Thus, there
should be a general increase in P-values. This will result in
more stringent PFP thresholds for the F6 as compared to
the same markers in the F2 or BC, and a consequent
reduction in power as compared to the BC. As will be
demonstrated in results, loss of power was especially
severe for ANOVA and IA. For ANOVA, loss in power due
to map expansion added to the loss of power due to use
of the interaction MS as error term. For IA, in addition to
the reduced P-values all along the genome, there will also
be a massive increase in the number of non-significant test
points (after taking three-fold map expansion into
account, the IA analysis included 12,753 individual
points). Since the number of QTL is fixed, the ratio of QTL
to test-points drops precipitously, with the vast majority
of test points representing true null hypotheses. This will
necessarily increase stringency of the threshold for a given
PFP, since total number of test points enters PFP calcula-
tion in the numerator. For this reason, we did not relate to
the actual PFP thresholds for ANOVA or IA, but to the
absolute P-values, and considered ANOVA and IA as sup-
porting significant Z-test and CS tests, respectively. In
some cases CS gave a significant P-value for a marker,
while IA gave P ≥ 0.50 for the same marker. In all such
instances, this was due to the fact that CS P-values for
markers closely flanking the significant marker were high
and not consistent with the low P-value of the significant
marker. Thus, IA was more correctly reflecting the overall
significance of the region. In these cases, the IA results
were taken as definitive, and the single significant CS
markers were attributed to technical error and therefore
not taken as indicating a linked QTL. When both IA and
CS indicated significance, the IA also provided a point
estimate of QTL location according to the cM of highest
significance, and a confidence interval of QTL location
according to the region for which P < 0.05.
Defining QTL containing regions (QTLR) and regions not 
containing QTL (non-Q regions)
Examination of the full set of marker test results showed
that significant markers most often appeared in short
stretches of two to five closely linked markers (in some
cases incorporating one or more non-significant markers).
These stretches of significant markers were flanked by
stretches of non-significant markers. Each such stretch of
one or more significant markers was taken to define a sin-
gle QTL containing chromosomal region (QTLR). The
flanking non-significant regions were taken to define
regions that did not contain QTL (non-Q regions). TheBMC Genomics 2009, 10:20 http://www.biomedcentral.com/1471-2164/10/20
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minimum extent of a QTLR is thus defined by the loca-
tions of the start and end markers of the QTLR; the maxi-
mum extent of a QTLR is defined as running from the
midpoint between the distal marker of the QTLR and the
proximal marker of the flanking upstream non-Q region
to the midpoint between the proximal marker of the
QTLR and the distal marker of the flanking downstream
non-Q region. For example, QTLR 1–IV extended from
245 to 248 cM. It was flanked upstream by non-Q region
1–V having proximal marker at 259 cM, and flanked
downstream by non-Q region 1–III having distal marker
at 243 cM. Thus, the minimum extent of this QTLR was 3
cM, running from 245 to 248 cM; and the maximum
extent of the QTLR was 9.5 cM, running from 244 cM to
253.5 cM.
Estimating allele substitution effects
Allele substitution effects for a given QTLR were calcu-
lated as described in Appendix I, from the average differ-
ences, D, in allele frequency of the alleles derived from
Line 2 in the resistant and susceptible pools. When a
QTLR was represented by multiple markers in the same
region, D was set equal to the weighted average Dijk-value
across the resistant and susceptible pools of the 18 BFjk
combinations within each of the Mi markers defining the
QTLR, weighted by the number of individuals in each
pool.
Searching for candidate genes in selected QTLR
The marker of interest for a specific QTL was identified in
chicken genome assembly Build 2. Based on the cM per
Kb from [45], the entire region was visualized on the
USCS browser [46]. Using the USCS browser all putative
genes in the region were identified using a variety of tools
to visualize the features and annotations (e.g., chicken
RefSeq, non-chicken RefSeq, chicken EST and mRNA).
The identified genes were manually examined for a poten-
tial role in MD pathogenesis.
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Appendix 1
Estimating the effects of individual markers on survival 
time
Let PR  and PS  be the proportion of total population
selected to construct the resistant and susceptible pools;
let αP be the observed allele substitution effect of the Line
2 marker allele relative to the Line 1 marker allele taken
over both of the selected tails of the population; and let αT
be the actual substitution effect in the population as a
whole. Then, substituting in the Darvasi and Soller [31]
expression, gives,
αT = αP/[(iPR + iPS)/2]2,
where,
iPX = XP/PX, (PX = PR or PS) is the selection intensity of the
pool,
XP is the ordinate of the standard normal distribution at
the point ZP which cuts off proportion P of the distribu-
tion.
In the present study, PS = 0.22 was calculated from Table
1 as the total number of birds taken to the susceptible
pools across all family and blood type combinations,
including the Type II susceptible pools; PR = 0.44 was cal-
culated from Table 1 as the weighted mean proportion
selected across all family and blood type combinations
with weighting according to the number of individuals in
the pool.
With pool data, αP is calculated as
αP = G2 - G1
where, taking into account that an F6 population is equiv-
alent to an F2 population with respect to expected geno-
type frequencies, and following Darvasi and Soller [31],BMC Genomics 2009, 10:20 http://www.biomedcentral.com/1471-2164/10/20
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G2 is the mean of individuals homozygous for the Line 2
allele taken over all resistant and susceptible pools,
G1 is the mean of individuals homozygous for the Line 1
allele taken over all resistant and susceptible pools.
Letting, FM2 and FM2S be the frequency of the Line 2 allele
(M2) in the resistant and susceptible pools, respectively,
and FM1R and FM1S be the same for the Line 1 allele, then
following Darvasi and Soller [31], relative frequency of
G2 and G1 in the resistant pool (RFG2R, RFG1R) and in the
susceptible pool (RFG2S, RFG1S) are estimated as
RFG2R = 2FM2R-0.5
RFG2S = 2FM2S-0.5
RFG1R = 2FM1R-0.5
RFG1S = 2FM1S-0.5
and,
G2 = RFG2R (TR) + RFG2S(TS)
G1 = RFG1R (TR) + RFG1S(TS)
Then, taking into account that
D = FM2R - FM2S = - (FM1R - FM1S),
we have with some algebra,
αP = G2 - G1 = 2D(TR-TS),
where
TR and TS are the mean survival time of the individuals in
the R and S pools, respectively.
In the present study, since all individuals taken to the
resistant pools survived until the end of the test, TR was
taken as the mean test cut-off age across the two hatches,
namely, 119.5 days; TS was taken as weighted mean sur-
vival time of the individuals in the susceptible pools, cal-
culated from Table 1 across all family and blood type
combinations = 63.02 days, with weighting according to
the number of individuals in the pool. Thus, TR - TS = 56.5
days, and αP = 2D(56.5) days.
As noted in Heifetz et al. [18], when applied to survival
data which have a right skewed distribution, the Darvasi
and Soller [31] correction factor, which is based on the
assumption of a normal distribution appears to provide
estimates of QTL effect that are about 10% greater than
the actual effects.
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